Eric Venker

CIK 1801917 · President & Immunovant CEO · last filed 2026-10-02

Eric Venker is a President & Immunovant CEO who has filed 170 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for ROIV, was dated Oct 2, 2026. Across all open-market trades the lifetime net is −$208.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $66.2M across reported positions. 165 SEC filings were submitted jointly with Roivant Sciences Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$66.16M

Companies

Total Filings

170

Lifetime Open-Market Net

-$208.23M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

C/O ROIVANT SCIENCES, INC.
7TH FLOOR, 50 BROADWAY
LONDON SW1H 0DB

Related Filers

Roivant Sciences Ltd. — 165 joint filings, latest 2026-09-01

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ROIV	President & Immunovant CEO	1,599,154	$35.95	$57.49M	-$184.40M	53	2026-10-02
IMVT	Chief Executive Officer	257,372	$33.68	$8.67M	-$461.8K	4	2026-07-06
Roivant Sciences Ltd. (ROIVW) Delisted	President & COO	611,813	$2.75	$1.68M	-$23.37M	32	2023-08-24

Recent Filings

170 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-10-02	ROIV	Mixed	—	-$6.55M	EDGAR
2026-09-30	ROIV	Notice (144)	−200,000	-$7.32M	EDGAR
2026-09-01	ROIV	Mixed	—	-$6.38M	EDGAR
2026-08-28	ROIV	Notice (144)	−200,000	-$7.15M	EDGAR
2026-08-24	ROIV	Tax (F)	−13,909	-$512.4K	EDGAR
2026-07-29	ROIV	Mixed	—	-$6.22M	EDGAR
2026-07-27	ROIV	Notice (144)	−200,000	-$6.99M	EDGAR
2026-07-06	IMVT	Mixed	+2,467	-$2.09M	EDGAR
2026-06-26	ROIV	Mixed	—	-$5.86M	EDGAR
2026-06-24	ROIV	Notice (144)	−200,000	-$6.63M	EDGAR

Showing 1–10 of 170

Page 1 of 17 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.